Clinical trials: Vitamin D Deficiency/Insufficiency
Secondary Hyperparathyroidism, Chronic Kidney Disease
Treatment of Secondary Hyperparathyroidism in the Uremic Patient
The purpose of this study is to compare alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients.
- Conditions
- Secondary Hyperparathyroidism, Chronic Kidney Disease, Vitamin D Deficiency
- Trial name
- NCT00469599
- Testing
- paricalcitol, alfacalcidol
- Where
- 8 sites in Denmark
- Volunteers
- 86 people
- Sponsor
- Zealand University Hospital
Secondary Hyperparathyroidism, Chronic Kidney Disease
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
This is an open label, single center, randomized, active comparator controlled study, comparing the effects of vitamin D replacement using oral ergocalciferol versus paricalcitol on parathyroid hormone (PTH) levels in patients…
- Trial name
- NCT00958451
- Testing
- Paricalcitol, Ergocalciferol
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- Salem Veterans Affairs Medical Center
Chronic Kidney Disease, Vitamin D Deficiency
Vitamin D, Chronic Kidney Disease (CKD) and the Microcirculation
Overall research aims: This study will examine the effect of vitamin D supplementation on the function of the endothelium and microcirculation of patients with chronic kidney disease and vitamin D deficiency.
- Trial name
- NCT00882401
- Testing
- Ergocalciferol (Vitamin D)
- Where
- United Kingdom
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- Barts & The London NHS Trust
Vitamin D Deficiency, Chronic Renal Insufficiency
Vitamin D and Chronic Renal Insufficiency
Purpose of this study is to investigate the effect of treatment with vitamin D3 (cholecalciferol) compared with placebo in a trial including chronic kidney disease patients with vitamin D deficiency.
- Trial name
- NCT00968877
- Testing
- Cholecalciferol
- Volunteers
- 56 people
- Sponsor
- Odense University Hospital
Chronic Kidney Disease
Ergocalciferol in Chronic Kidney Disease
To examine the effect of ergocalciferol treatment on 25-hydroxyvitamin D and PTH levels in patients with CKD stage 3 and 4
- Trial name
- NCT00411294
- Where
- United States
- Sponsor
- Saint Louis VA Medical Center